Hypoloc (Nebivolol)

Nebivolol works by selectively blocking β1‑adrenergic receptors in the heart, which slows heart rate and reduces contractile force. At the same time, it stimulates nitric‑oxide production in blood vessels, causing them to relax and widen. This combined effect lowers systemic vascular resistance and overall blood pressure without markedly affecting β2 receptors in the lungs.

The appropriate dose of Hypoloc is individualized by a qualified prescriber based on the patient’s medical condition, response to therapy, and any concomitant medications. Physicians determine the starting dose and any subsequent adjustments, so patients should follow the specific instructions provided by their healthcare professional.

Safety data for nebivolol in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their doctor.

To request Hypoloc, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. After the enquiry, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain needs), and required import documentation.

Compared with older non‑selective beta‑blockers such as propranolol, nebivolol offers higher β1 selectivity and an additional nitric‑oxide‑mediated vasodilatory effect, which can improve tolerability and reduce peripheral side effects. Relative to agents like atenolol, nebivolol may provide better blood‑pressure control with a lower incidence of metabolic disturbances, though individual response varies.

Hypoloc should be stored at ambient temperature, ideally below 25 °C. Keep the tablets in their original container, protect them from moisture and direct light, and ensure the packaging remains tightly closed. Do not store in areas with high humidity or extreme heat, and keep out of reach of children.

Hypoloc is taken orally as a tablet. Patients should swallow the tablet whole with a glass of water, and it may be taken with or without food. The dosing schedule—usually once daily—should be followed exactly as prescribed, and missed doses should be taken as directed by the prescriber.

The most serious adverse reactions include severe bradycardia, second‑ or third‑degree heart block, and hypersensitivity reactions such as rash, angioedema, or anaphylaxis. Patients should seek immediate medical attention if they experience fainting, unusually slow heart rate, chest discomfort, or signs of an allergic reaction while on the medication.

Hypoloc is contraindicated in individuals with severe bradycardia (heart rate below 45 bpm), second‑ or third‑degree atrioventricular block, cardiogenic shock, uncontrolled heart failure, or severe hepatic impairment. Patients with known hypersensitivity to nebivolol or any excipients in the tablet should also avoid using this medication.